Mutant Mitochondrial Elongation Factor G1 and Combined Oxidative Phosphorylation Deficiency
Author(s) -
Marieke J. H. Coenen,
Hana Antonická,
Cristina Ugalde,
Florin Sasarman,
R Rossi,
J. G. A. M. Heister,
Robert F. Newbold,
Frans J.M. Trijbels,
Lambert P. van den Heuvel,
Eric A. Shoubridge,
Jan Smeitink
Publication year - 2004
Publication title -
new england journal of medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 19.889
H-Index - 1030
eISSN - 1533-4406
pISSN - 0028-4793
DOI - 10.1056/nejmoa041878
Subject(s) - mitochondrial dna , oxidative phosphorylation , biology , mitochondrial disease , mitochondrion , atp–adp translocase , genetics , gene , phosphorylation , human mitochondrial genetics , mutation , microbiology and biotechnology , biochemistry , inner mitochondrial membrane
Although most components of the mitochondrial translation apparatus are encoded by nuclear genes, all known molecular defects associated with impaired mitochondrial translation are due to mutations in mitochondrial DNA. We investigated two siblings with a severe defect in mitochondrial translation, reduced levels of oxidative phosphorylation complexes containing mitochondrial DNA (mtDNA)-encoded subunits, and progressive hepatoencephalopathy. We mapped the defective gene to a region on chromosome 3q containing elongation factor G1 (EFG1), which encodes a mitochondrial translation factor. Sequencing of EFG1 revealed a mutation affecting a conserved residue of the guanosine triphosphate (GTP)-binding domain. These results define a new class of gene defects underlying disorders of oxidative phosphorylation.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom